COVID pivot at Davos, betting on personalised mRNA cancer therapies, new vaccine launches, and AI-led drug development to ...
LONDON — Swiss biotech firm Relief Therapeutics has seen its share price climb by 38,000% so far this year, as it develops a drug focused on respiratory failure arising from severe Covid-19. Last week ...
Journal Star on MSN
Planning a family trip to Illinois? See how travel costs surged post-COVID
A new study ranked the most expensive cities to travel to as a family post-pandemic. Here's how Illinois travel hubs fared.
AU Small Finance Bank CEO Sanjay Agarwal shares growth journey, tech adoption, and future plans, highlighting partnerships ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results